Jeremy Yarwood, a chief scientific officer at Neogen Corp, sells $114,676 of stock
The chief scientific officer sold at an average of $12.67 a share, according to a Form 4 filed with the SEC on Nov 4. Information only, not investment advice.
Jeremy Yarwood sold $114,676 of Neogen Corp (NEOG) stock on Nov 4, according to an SEC filing. The chief scientific officer received an average of $12.67 for 9,051 shares.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. The sale leaves the insider with no shares reported in this form of ownership.
The trade was reported within two business days, as Section 16 requires.
Details from the SEC filing:
| Company | Neogen Corp (NEOG) |
|---|---|
| Insider | Jeremy Yarwood |
| Role | Chief Scientific Officer |
| Transaction | Open-market sale (code S) |
| Shares | 9,051 |
| Average price | $12.67 |
| Value | $114,676 |
| Trade date | Nov 4, 2026 |
| Filed with the SEC | Nov 4, 2026, 4:10 PM ET |
| Shares held after | 0 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See the detailed report on this NEOG sale
Read more NEOG insider trading news · Browse the insider trading newsroom
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
Related Articles
- Insider Trading News
Gen Digital Inc. officer Travis Michael Witteveen sells $892,422 in shares
- Insider Trading News
Nucor Corp officer Michael D Keller sells 1,136 shares worth $317,323
- Insider Trading News
Enova International, Inc. chief strategy officer Kirk Chartier sells $4.8M of ENVA stock
- Insider Trading News
CEO Steven E Cunningham sells $2.63M of Enova International, Inc. stock
- Insider Trading News
Christine Ring, a chief legal officer at Nurix Therapeutics, Inc., sells $103,986 of stock